Description
DTT 300
- Drostanolone Propionate 100mg/ml
- Trenbolone Acetate 100mg/ml
- Testosterone Propionate 100mg/ml
DTT 300 is a powerful tri-blend formulation designed for athletes seeking peak definition, explosive strength, and muscle hardness. Each milliliter delivers a potent 1:1:1 ratio of three fast-acting compounds: Drostanolone Propionate (Masteron), Trenbolone Acetate, and Testosterone Propionate.
This synergy promotes rapid improvements in vascularity, aggression in training, and dense muscle appearance—especially during cutting or contest preparation phases. Drostanolone enhances definition and firmness, Trenbolone boosts nitrogen retention and metabolic efficiency, while Testosterone Propionate ensures hormonal balance and anabolic drive.
Application:
Ideal for short-duration cutting cycles or advanced users looking to maintain muscle while aggressively reducing body fat. Due to the short esters, DTT 300 requires frequent dosing (every other day) for optimal stability and results.
Important Note:
This blend is highly androgenic and not recommended for beginners. Proper post-cycle therapy is essential to restore hormonal balance.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.